ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 695,78
0,83%
Dow Jones
39 308,00
-0,06%
DAX
18 450,48
0,38%
Brent Oil
87,22
0,36%
Bitcoin
58 225,58
-3,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Progenics Pharmaceuticals Inc (PGNX)

  7. Progenics Pharmaceuticals Inc (PGNX) Actualités

PGNX

Progenics Pharmaceuticals (PGNX)

Progenics Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PGNX
DateHeureSourceTitreSymboleSociété
08/02/202218h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
23/06/202022h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202014h29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202014h11Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202013h55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202013h00Business WireLantheus Completes Merger with ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
17/06/202023h33PR Newswire (US)Independent Bank Group Set to Join S&P SmallCap 600NASDAQ:PGNXProgenics Pharmaceuticals Inc
16/06/202022h05GlobeNewswire Inc.Progenics Stockholders Approve Merger with LantheusNASDAQ:PGNXProgenics Pharmaceuticals Inc
28/05/202001h53PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.NASDAQ:PGNXProgenics Pharmaceuticals Inc
18/05/202014h30GlobeNewswire Inc.Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society ...NASDAQ:PGNXProgenics Pharmaceuticals Inc
14/05/202015h13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
12/05/202022h33Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PGNXProgenics Pharmaceuticals Inc
08/05/202023h14PR Newswire (US)Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceutica...NASDAQ:PGNXProgenics Pharmaceuticals Inc
07/05/202022h09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PGNXProgenics Pharmaceuticals Inc
07/05/202013h30GlobeNewswire Inc.Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business UpdateNASDAQ:PGNXProgenics Pharmaceuticals Inc
23/04/202023h01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PGNXProgenics Pharmaceuticals Inc
23/04/202014h30GlobeNewswire Inc.Progenics Pharmaceuticals Sets First Quarter 2020 Financial Results and Business Update Call for May 7NASDAQ:PGNXProgenics Pharmaceuticals Inc
15/04/202021h16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
14/04/202017h17Business WireADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
14/04/202015h00Business WireVelan Capital Agrees to Support Merger of Lantheus and ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
19/03/202014h06Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
13/03/202021h08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PGNXProgenics Pharmaceuticals Inc
13/03/202013h30GlobeNewswire Inc.PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTSNASDAQ:PGNXProgenics Pharmaceuticals Inc
20/02/202017h30Business WireLantheus and Progenics Agree to Amended Transaction TermsNASDAQ:PGNXProgenics Pharmaceuticals Inc
14/02/202019h42Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PGNXProgenics Pharmaceuticals Inc
06/02/202014h30GlobeNewswire Inc.Progenics Pharmaceuticals Announces Presentations at the 2020 American Society of Clinical Oncology Genitourinary Cancers Sym...NASDAQ:PGNXProgenics Pharmaceuticals Inc
21/01/202022h15GlobeNewswire Inc.Progenics Pharmaceuticals Provides Update on Reconstituted Board’s Ongoing Strategic ReviewNASDAQ:PGNXProgenics Pharmaceuticals Inc
16/01/202015h10GlobeNewswire Inc.Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter MeetingNASDAQ:PGNXProgenics Pharmaceuticals Inc
23/12/201913h00GlobeNewswire Inc.Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary EndpointNASDAQ:PGNXProgenics Pharmaceuticals Inc
22/12/201923h00GlobeNewswire Inc.Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyL...NASDAQ:PGNXProgenics Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PGNX

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
FTSE
UKX
FTSE 100
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
EU
VK
Vallourec
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
EU
PX4
SBF 120
EU
DG
Vinci
EU
ML
Michelin
COIN
BTCUSD
Bitcoin
EU
CAP
Capgemini
NYSE
NKE
Nike
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés